Molecular Partners (MOLN)
NASDAQ:MOLN
Holding MOLN?
Track your performance easily

Molecular Partners (MOLN) Financial Statements

19 Followers

Molecular Partners Financial Overview

Molecular Partners's market cap is currently ―. The company's EPS TTM is $-1.969; its P/E ratio is -2.41; Molecular Partners is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--CHF 2.34MCHF 11.75MCHF 172.78M
Gross Profit-----
EBIT--CHF -13.21MCHF -4.28MCHF 153.37M
EBITDA--CHF -12.63MCHF -3.70MCHF 154.00M
Net Income Common Stockholders--CHF -13.32MCHF -4.52MCHF 153.13M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsCHF 186.89MCHF 249.14MCHF 267.13MCHF 285.07MCHF 296.25M
Total AssetsCHF 198.35MCHF 262.26MCHF 281.16MCHF 299.29MCHF 311.84M
Total DebtCHF 3.65MCHF 4.85MCHF 5.15MCHF 5.45MCHF 5.74M
Net DebtCHF -183.24MCHF -244.29MCHF -261.99MCHF -279.62MCHF -290.51M
Total LiabilitiesCHF 21.92MCHF 27.09MCHF 29.73MCHF 33.42MCHF 47.34M
Stockholders EquityCHF 176.43MCHF 231.56MCHF 251.43MCHF 265.87MCHF 264.50M
Cash Flow-
Free Cash Flow--CHF -18.41MCHF -12.73MCHF 163.18M
Operating Cash Flow--CHF -18.15MCHF -12.58MCHF 163.56M
Investing Cash Flow--CHF -27.42MCHF -16.04MCHF -93.56M
Financing Cash Flow--CHF -923.00KCHF -279.00KCHF -70.00K
Currency in CHF

Molecular Partners Earnings and Revenue History

Molecular Partners Debt to Assets

Molecular Partners Cash Flow

Molecular Partners Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis